BNP Paribas Financial Markets
TYRA icon

BNP Paribas Financial Markets’s Tyra Biosciences TYRA Stock Holding History

BNP Paribas Financial Markets’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.28M Buy
190,039
+69,761
+58% +$2.26M ﹤0.01% 1760
2025
Q4 		$3.16M Sell
120,278
-8,603
-7% -$158K ﹤0.01% 2329
2025
Q3 		$1.8M Buy
128,881
+31,145
+32% +$355K ﹤0.01% 2681
2025
Q2 		$935K Buy
97,736
+28,786
+42% +$274K ﹤0.01% 2949
2025
Q1 		$641K Buy
68,950
+64,632
+1,497% +$836K ﹤0.01% 3036
2024
Q4 		$60K Buy
+4,318
New +$78.4K ﹤0.01% 4351

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BNP Paribas Financial Markets's TYRA Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Tyra Biosciences (TYRA) stake by 58% in Q1 2026, buying an estimated $2.26M and bringing the position to 190,039 shares worth $7.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

BNP Paribas Financial Markets first reported a position in TYRA in Q4 2024 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • BNP Paribas Financial Markets held 190,039 shares of Tyra Biosciences worth $7.28M as of Q1 2026.
  • BNP Paribas Financial Markets bought 69,761 Tyra Biosciences shares in Q1 2026, an estimated $2.26M.
  • Tyra Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #1760 holding.
  • BNP Paribas Financial Markets first reported a position in Tyra Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.